Incyte to Buy Vega Therapeutics For Up to $2 Billion

1 day ago 1
Incyte has agreed to bargain Vega Therapeutics for up to $2 cardinal successful a woody that expands the biopharmaceutical company’s hematology portfolio into bleeding disorders.
Read Entire Article